|
Real-time Estimate
Cboe BZX
11:54:31 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 6.705 USD | +1.44% |
|
-1.75% | -15.58% |
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-10 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: DiaMedica Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 124.8 | 56.55 | 142.3 | 334.1 | 568.4 | 495.2 | - | - |
| Change | - | -54.69% | 151.72% | 134.69% | 70.13% | -12.88% | - | - |
| Enterprise Value (EV) | 124.8 | 56.55 | 142.3 | 334.1 | 568.4 | 495.2 | 495.2 | 495.2 |
| Change | - | -54.69% | 151.72% | 134.69% | 70.13% | -12.88% | 0% | 0% |
| P/E | -5.74x | -3.04x | -4.73x | -9.05x | -11.4x | -8.14x | -8.18x | -6.5x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | -0.3x | - | -0.7x | -0.5x | 14.77x | -0.3x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 77.1x |
| EV / Revenue | - | - | - | - | - | - | - | 77.1x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -8.06x | -7.45x | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.69x | -6.86x | -4.71x |
| EV / FCF | - | - | - | -0x | -0x | -8.03x | -7.33x | -5.4x |
| FCF Yield | - | - | - | -9.45% | -7.15% | -12.5% | -13.6% | -18.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.65 | -0.52 | -0.6 | -0.6 | -0.7 | -0.8125 | -0.808 | -1.017 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 6.42 |
| EBITDA 1 | - | - | -28.81 | -38.06 | -47.83 | -61.43 | -66.45 | - |
| EBIT 1 | -17.41 | -19.07 | -28.85 | -38.12 | -47.89 | -64.43 | -72.23 | -105.1 |
| Net income 1 | -17.34 | -18.63 | -26.3 | -34.92 | -45.62 | -62.74 | -71.13 | -103.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.730 | 1.580 | 2.840 | 5.430 | 7.960 | 6.610 | 6.610 | 6.610 |
| Nbr of stocks (in thousands) | 26,439 | 26,443 | 37,954 | 42,761 | 52,077 | 53,926 | - | - |
| Announcement Date | 3/14/22 | 3/28/23 | 3/19/24 | 3/17/25 | 3/30/26 | - | - | - |
1CAD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.14x | - | - | - | 356M | |
| 22.02x | 7.72x | 15.73x | 1.34% | 73.45B | |
| 36.15x | 9.26x | 28.49x | 0.04% | 62.99B | |
| -81.2x | 15.18x | -77.46x | -.--% | 28.05B | |
| 32.25x | 6.34x | 16.79x | -.--% | 25.42B | |
| -14.35x | 5.17x | -6.66x | -.--% | 23.3B | |
| 26.57x | 5.01x | 16.8x | -.--% | 19.45B | |
| 52.91x | 19.58x | 39.65x | 0.29% | 18.16B | |
| -7088.72x | 40.96x | -262.55x | -.--% | 16.53B | |
| 16.43x | 4.87x | 11.36x | -.--% | 13.16B | |
| Average | -700.61x | 12.68x | -24.21x | 0.19% | 28.09B | |
| Weighted average by Cap. | -403.69x | 10.88x | -7.47x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DMAC Stock
- Valuation DiaMedica Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
